Related Experiment Video
Updated: Apr 19, 2026

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
Published on: July 18, 2017
Model-informed cefepime dosing in paediatric patients receiving continuous renal replacement therapy
Ronaldo Morales Junior1, Shannon Reinert2, Emily Diseroad3
1Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Model-informed precision dosing (MIPD) optimized cefepime therapy for critically ill children on continuous renal replacement therapy (CRRT). This approach ensured effective antibiotic levels, avoiding toxicity and subtherapeutic exposures in pediatric CRRT patients.
Area of Science:
- Pediatric Critical Care Medicine
- Pharmacokinetics and Pharmacodynamics
- Renal Replacement Therapy
Background:
- Critically ill children on CRRT face unpredictable cefepime exposure due to altered pharmacokinetics.
- Subtherapeutic or toxic antibiotic levels can result from patient factors and CRRT parameters.
- Optimizing cefepime dosing is crucial for effective treatment in this vulnerable population.
Purpose of the Study:
- To describe the use of model-informed precision dosing (MIPD) for guiding cefepime therapy in pediatric patients undergoing CRRT.
- To assess the feasibility and clinical utility of MIPD in achieving therapeutic cefepime concentrations.
- To identify key factors influencing cefepime pharmacokinetics during CRRT.
Main Methods:
- A case series of five critically ill pediatric patients receiving cefepime and CRRT.
- Individual pharmacokinetic analyses using measured cefepime concentrations and a population PK model with a CRRT module.
- Inclusion of CRRT prescription variables (effluent flow rate, blood flow, filter type) in the PK model.
- Assessment of residual urine output and CRRT effluent flow rate as predictors of drug clearance.
Main Results:
- CRRT contributed significantly to total cefepime clearance (26.9%–83.4%) across cases.
- Residual urine output and CRRT effluent flow rate were identified as key predictors of cefepime clearance.
- Extended cefepime infusions were required in three patients to reach target pharmacodynamic goals.
- No patients required dose reduction due to concerns of excessive drug exposure.
Conclusions:
- MIPD is a feasible and clinically useful strategy for optimizing cefepime dosing in pediatric CRRT.
- Bedside pharmacokinetic consultation, incorporating patient-specific and CRRT factors, enhances cefepime therapy.
- This approach helps achieve therapeutic targets and avoid adverse antibiotic exposures in critically ill children on CRRT.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Continuous Renal Replacement Therapy
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Drug Dosing: Infants and Children

